XNCR Xencor announces proffered Paper oral presentation at esmo 2026 for phase 1 clinical study of xmab819 in advanced clear cell renal cell

XNCR Xencor announces proffered Paper oral presentation at esmo 2026 for phase 1 clinical study of xmab819 in advanced clear cell renal cell carcinoma